Medical device company Nanochon will buy $1.5 million worth of biologic company Bico’s products and services to develop the implants, according to a Dec. 9 news release. Nanochon’s joint implant technology is designed to speed up patient recovery and reduce healthcare costs.
Bico’s dispensing company, Scienion, will serve as a contract manufacturer for cartilage resurfacing implants under the deal with Nanochon. Bico is also investing $400,000 in Nanochon’s seed funding to help advance regenerative medicine technology.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
